Navigation Links
IDEXX Laboratories Announces First Customer Deliveries of Catalyst Dx(TM) Chemistry Analyzer and SNAPshot Dx(TM) Analyzer
Date:4/2/2008

WESTBROOK, Maine, April 2, 2008 /PRNewswire-FirstCall/ -- IDEXX Laboratories, Inc. (Nasdaq: IDXX) today announced that it has shipped, delivered and recognized first quarter revenue for initial customer deliveries and installations of its two next-generation point-of-care analyzers: the Catalyst Dx(TM) for chemistry analysis and the SNAPshot Dx(TM) for endocrinology testing. Catalyst Dx combines the convenience of immediate results with the accuracy, flexibility, and menu breadth of a reference laboratory, and SNAPShot Dx provides the ability to quickly and conveniently screen for hypothyroidism, hyperthyroidism, Cushing's syndrome, Addison's disease, liver disease and other conditions at the point of care.

Both Catalyst Dx and SNAPshot Dx offer veterinarians enhancements in ease-of-use, speed-to-result, accuracy and throughput, with the ability to run multiple samples for more than one patient simultaneously. In addition, each instrument captures all results in the electronic medical record and automatically integrates the data into the patient diagnostic report and invoice, improving overall practice productivity and workflow efficiencies.

"I am very pleased that we are delivering these important new products on the schedule we outlined over a year ago," said Jonathan W. Ayers, Chairman and Chief Executive Officer. "We have successfully met the key milestones for this complex project, concurrently completing the development, field test and validation for two major diagnostic instrument systems."

The addition of these two innovative instruments to the IDEXX VetLab(R) Suite of in-house analyzers continues the IDEXX tradition of delivering new technologies to the veterinary market that expand the range of point-of-care testing capabilities available to veterinarians. The IDEXX VetLab Suite is a highly integrated set of veterinary analyzers that provides fast and flexible results on a patient's blood and urine within minutes of the pet visit. Diagnostic capabilities of the Suite include clinical chemistry, electrolytes, hematology with five-part differential and reticulocytes, endocrinology, blood gases, coagulation, urinalysis and infectious diseases. The IDEXX VetLab(R) Station, which serves as an information system for the in-house laboratory, uses the power of SmartLink(TM) technology to integrate results from all the analyzers-including the new Catalyst Dx and SNAPshot Dx-and IDEXX SNAP(R) point-of-care tests into a single comprehensive and easy-to-use patient report and stores this information in its database for easy future reference and historical results-trending capability.

About IDEXX Laboratories

IDEXX Laboratories, Inc. is a leader in companion animal health, serving practicing veterinarians around the world with innovative, technology-based offerings, including a broad range of diagnostic products and services, practice management systems and pharmaceuticals. IDEXX products enhance the ability of veterinarians to provide advanced medical care and to build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for the production animal industry and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX Laboratories employs more than 4,500 people and offers products to customers in over 100 countries.

Contact: Merilee Raines, Chief Financial Officer, 1-207-556-8155

(Logo: http://www.newscom.com/cgi-bin/prnh/20030305/IDEXXLOGO )


'/>"/>
SOURCE IDEXX Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Stonegate Report About Unigene Laboratories Inc.
2. Ardea Biosciences to Move Headquarters and R&D Laboratories to San Diego
3. White Paper Details Environmental Health & Safety Compliance Strategies for Laboratories
4. Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement
5. Forest Laboratories, Inc. Announces Positive Results of Memantine Study of Once-Daily Formulation
6. Clontech Laboratories, Inc. Releases the ProteoTuner(TM) Systems
7. Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KgaA File Additional Lawsuit Against Several Companies for Patent Infringement
8. Alfacell Announces ONCONASE(R) Purchase and Supply Agreement with Scientific Protein Laboratories
9. Romark Laboratories Names Emmet B. Keeffe, M.D. Vice President and Chief Medical Officer
10. Free White Paper Helps Biotech Laboratories Maintain a High Level of Infection Control
11. Carrington Laboratories Common Stock Now Trading on the OTC Bulletin Board: CARN.OB
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... 26, 2017 , ... WonderWorks, Myrtle Beach’s science focused amusement ... of deep space exploration and inspire space enthusiasts. The exhibit features interactive exhibits ... guest appearance by former Shuttle Astronaut Don Thomas. , The intergalactic weekend kicks ...
(Date:4/26/2017)... ... April 26, 2017 , ... As the call ... healthcare industry stakeholders, the discussion surrounding the topic will continue at WEDI 2017- ... in Los Angeles, Calif. Hosted by the Workgroup for Electronic Data Interchange (WEDI), ...
(Date:4/25/2017)... R.I. , April 25, 2017 ... Inc. ("EpiVax") has licensed its novel immune-modulating technology to ... autoimmune disease and allergy. Tregitopes, pronounced ... in human immunoglobulin by EpiVax CEO Annie ... Similar to intravenous immunoglobulin G, an autoimmune disease ...
(Date:4/24/2017)... , April 24, 2017  Dante Labs announced today the ... EUR 850 (ca. $900). While American individuals have been able ... time Europeans can access WGS below EUR 1,000. ... to leveraging genetic information to make informed decisions about disease ... ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 5, 2017  The Allen Institute for ... Cell Explorer: a one-of-a-kind portal and dynamic digital window ... imaging data, the first application of deep learning to ... stem cell lines and a growing suite of powerful ... for these and future publicly available resources created and ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/29/2017)... 29, 2017  higi, the health IT company that ... North America , today announced a Series B ... of EveryMove. The new investment and acquisition accelerates higi,s ... to transform population health activities through the collection and ... higi collects and secures data today on behalf ...
Breaking Biology News(10 mins):